BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 29459538)

  • 1. [Development of a Striatal and Skull Phantom for Quantitative
    Ishiguro M; Uno M; Miyazaki T; Kataoka Y; Toyama H; Ichihara T
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2018; 74(2):124-132. PubMed ID: 29459538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Semiquantitative analysis using standardized uptake value in
    Toriihara A; Daisaki H; Yamaguchi A; Kobayashi M; Furukawa S; Yoshida K; Isogai J; Tateishi U
    Clin Imaging; 2018; 52():57-61. PubMed ID: 29909364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of Realistic Striatal Digital Brain (SDB) Phantom for
    Furuta A; Onishi H; Nakamoto K
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2017; 73(10):1018-1027. PubMed ID: 29057773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precise Evaluation of Striatal Oxidative Stress Corrected for Severity of Dopaminergic Neuronal Degeneration in Patients with Parkinson's Disease: A Study with 62Cu-ATSM PET and 123I-FP-CIT SPECT.
    Neishi H; Ikawa M; Okazawa H; Tsujikawa T; Arishima H; Kikuta KI; Yoneda M
    Eur Neurol; 2017; 78(3-4):161-168. PubMed ID: 28848099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease.
    Tissingh G; Booij J; Bergmans P; Winogrodzka A; Janssen AG; van Royen EA; Stoof JC; Wolters EC
    J Nucl Med; 1998 Jul; 39(7):1143-8. PubMed ID: 9669384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of iterative reconstruction parameters with 3-dimensional resolution recovery, scatter and attenuation correction in ¹²³I-FP-CIT SPECT.
    Matsutomo N; Nagaki A; Yamao F; Sasaki M
    Ann Nucl Med; 2015 Aug; 29(7):636-42. PubMed ID: 25997807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 123I-FP-CIT SPECT imaging of dopamine transporters in patients with cerebrovascular disease and clinical diagnosis of vascular parkinsonism.
    Lorberboym M; Djaldetti R; Melamed E; Sadeh M; Lampl Y
    J Nucl Med; 2004 Oct; 45(10):1688-93. PubMed ID: 15471834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. European multicentre database of healthy controls for [123I]FP-CIT SPECT (ENC-DAT): age-related effects, gender differences and evaluation of different methods of analysis.
    Varrone A; Dickson JC; Tossici-Bolt L; Sera T; Asenbaum S; Booij J; Kapucu OL; Kluge A; Knudsen GM; Koulibaly PM; Nobili F; Pagani M; Sabri O; Vander Borght T; Van Laere K; Tatsch K
    Eur J Nucl Med Mol Imaging; 2013 Jan; 40(2):213-27. PubMed ID: 23160999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease.
    Booij J; Habraken JB; Bergmans P; Tissingh G; Winogrodzka A; Wolters EC; Janssen AG; Stoof JC; van Royen EA
    J Nucl Med; 1998 Nov; 39(11):1879-84. PubMed ID: 9829575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of nonuniform attenuation correction in quantitative brain SPECT imaging.
    Rajeevan N; Zubal IG; Ramsby SQ; Zoghbi SS; Seibyl J; Innis RB
    J Nucl Med; 1998 Oct; 39(10):1719-26. PubMed ID: 9776276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 123I-FP-CIT SPECT imaging of the dopaminergic state. Visual assessment of dopaminergic degeneration patterns reflects quantitative 2D operator-dependent and 3D operator-independent techniques.
    Kahraman D; Eggers C; Holstein A; Schneider C; Pedrosa DJ; Dietlein M; Kobe C; Timmermann L; Schmidt M
    Nuklearmedizin; 2012; 51(6):244-51. PubMed ID: 22526237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of Reconstruction Strategies for the Quantification and Diagnostic Accuracy of (123)I-FP-CIT SPECT].
    Kameiyama H; Matsutomo N; Nagaki A; Yamao F
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2016 Jul; 72(7):595-601. PubMed ID: 27440703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Count-based method for specific binding ratio calculation in [I-123]FP-CIT SPECT analysis.
    Rahman MGM; Islam MM; Tsujikawa T; Kiyono Y; Okazawa H
    Ann Nucl Med; 2019 Jan; 33(1):14-21. PubMed ID: 30276622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of semiquantitative analysis for clinical reporting of 123I-2-β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl)nortropane SPECT studies.
    Söderlund TA; Dickson JC; Prvulovich E; Ben-Haim S; Kemp P; Booij J; Nobili F; Thomsen G; Sabri O; Koulibaly PM; Akdemir OU; Pagani M; van Laere K; Asenbaum-Nan S; George J; Sera T; Tatsch K; Bomanji J
    J Nucl Med; 2013 May; 54(5):714-22. PubMed ID: 23492885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitation of specific binding ratio in
    Furuta A; Onishi H; Amijima H
    Radiol Phys Technol; 2018 Jun; 11(2):219-227. PubMed ID: 29700797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 123I-FP-CIT SPECT [(123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography] Imaging in a p.A53T α-synuclein Parkinson's disease cohort versus Parkinson's disease.
    Koros C; Simitsi A; Prentakis A; Beratis I; Papadimitriou D; Kontaxopoulou D; Fragkiadaki S; Papagiannakis N; Seibyl J; Marek K; Papageorgiou SG; Trapali XG; Stamelou M; Stefanis L
    Mov Disord; 2018 Nov; 33(11):1734-1739. PubMed ID: 30288781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlations between dopamine transporter density measured by
    Maekawa T; Sato N; Ota M; Sugiyama A; Sone D; Enokizono M; Kimura Y; Mukai Y; Murata M; Takano H; Imabayashi E; Matsuda H; Kunimatsu A; Abe O
    Jpn J Radiol; 2017 Dec; 35(12):755-759. PubMed ID: 29063467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of the Each Correction Method for the Specific Binding Ratio and Standardized Uptake Value in the Dopamine Transporter SPECT].
    Shiokawa A; Onoguchi M; Shibutani T; Maeda Y; Yoneyama H; Konishi T; Wakabayashi H
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2019; 75(7):638-645. PubMed ID: 31327774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features and 123I-FP-CIT SPECT imaging in vascular parkinsonism and Parkinson's disease.
    Benítez-Rivero S; Marín-Oyaga VA; García-Solís D; Huertas-Fernández I; García-Gómez FJ; Jesús S; Cáceres MT; Carrillo F; Ortiz AM; Carballo M; Mir P
    J Neurol Neurosurg Psychiatry; 2013 Feb; 84(2):122-9. PubMed ID: 22906618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigating dopaminergic neurotransmission with 123I-FP-CIT SPECT: comparability of modern SPECT systems.
    Meyer PT; Sattler B; Lincke T; Seese A; Sabri O
    J Nucl Med; 2003 May; 44(5):839-45. PubMed ID: 12732687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.